PURQUEST
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or Invalidated
What this record means
The record shows that PURQUEST is an abandoned application – the USPTO marked it “dead” after no Statement of Use was filed, with the abandonment notice and final abandonment both dated Oct 9 2025, and the owner listed as PurMinds Neuropharma Inc., a Canadian corporation. The filing covered two classes: 041 (education and entertainment) for “provision of libraries in the nature of databases featuring compounds, molecules and formulations for treatment and prevention in the field of psychiatric and neurological disorders, neurodegenerative diseases, and Alzheimer’s disease,” and 042 (scientific and technology services) for “provision of databases featuring compounds, molecules and formulations for scientific research and drug discovery in the same fields.” A similar name would raise the closest record‑based concern if used for comparable scientific‑research or medical‑database services, but the record does not give the owner control over every use of the word “PURQUEST” in other areas. The prosecution history shows the application moved from a notice of allowance in February 2023 to a series of extensions for filing a Statement of Use, ultimately ending in abandonment when no use statement was submitted. No oppositions, cancellations, or court actions appear in the supplied history. I'd treat this as a meaningful concern if you plan a database or research service in those medical fields, but the risk is far lower for unrelated goods or services.
Informational only - not legal advice.Mark Service Mark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Intent-to-Use (§1(b)). |
| Status | Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Nov 29, 2021 |
| Published for opposition | Dec 20, 2022 |
| Notice of Allowance | Feb 14, 2023 |
| Status date | Oct 09, 2025 |
Goods & services
Provision of libraries in the nature of databases featuring compounds, molecules and formulations for treatment and prevention in the field of psychiatric and neurological disorders, neurodegenerative diseases, and Alzheimer's disease
Provision of databases featuring compounds, molecules and formulations for scientific research and drug discovery in the field of psychiatric and neurological disorders, neurodegenerative diseases, and Alzheimer's disease
Owner & representation
| Owner | PurMinds Neuropharma Inc. |
| Address | 1 Concorde Gate, Suite 604, Toronto, Ontario CANADA M3C4H9 |
| Entity | CORPORATION - organized in CANADA |
| Attorney of record | Philip L. Conrad |
| Correspondent | Philip L. Conrad |
| Attorney email | d********@*****.com |
| Correspondent email | 5 emails |
| Correspondent phone | 1********4 |
| Correspondent address | Montreal, Quebec |